| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.708 | 0.005 | 0.746 | DNA damaging | 0.746 0.004 DBMET03698 0.489 0.015 DBMET03699 | DBMET03698 | |
| 0.592 | 0.003 | 0.652 | Tyrosine 3 hydroxylase inhibitor | 0.453 0.005 DBMET03698 0.652 0.003 DBMET03699 | DBMET03699 | |
| 0.574 | 0.004 | 0.668 | Alkylator | 0.668 0.003 DBMET03698 0.426 0.007 DBMET03699 | DBMET03698 | |
| 0.484 | 0.009 | 0.611 | Anesthetic general | 0.603 0.004 DBMET03698 0.611 0.004 DBMET03699 | DBMET03699 | |
| 0.492 | 0.024 | 0.594 | Spasmolytic | 0.594 0.013 DBMET03698 0.477 0.026 DBMET03699 | DBMET03698 | |
| 0.483 | 0.015 | 0.486 | DNA synthesis inhibitor | 0.486 0.014 DBMET03698 0.363 0.028 DBMET03699 | DBMET03698 | |
| 0.437 | 0.051 | 0.437 | Immunosuppressant | 0.428 0.054 DBMET03698 0.326 0.099 DBMET03699 | ||
| 0.389 | 0.004 | 0.389 | Glutamate dehydrogenase inhibitor | 0.236 0.008 DBMET03698 0.249 0.007 DBMET03699 | ||
| 0.399 | 0.014 | 0.405 | 5 Hydroxytryptamine uptake stimulant | 0.267 0.066 DBMET03698 0.405 0.013 DBMET03699 | DBMET03699 | |
| 0.377 | 0.005 | 0.377 | Aminopeptidase B inhibitor | 0.332 0.007 DBMET03698 0.327 0.007 DBMET03699 | ||
| 0.406 | 0.048 | 0.448 | Immunostimulant | 0.432 0.041 DBMET03698 0.448 0.037 DBMET03699 | DBMET03699 | |
| 0.383 | 0.033 | 0.423 | Interleukin 2 agonist | 0.364 0.039 DBMET03698 0.423 0.021 DBMET03699 | DBMET03699 | |
| 0.347 | 0.004 | 0.607 | Phenylalanine 4-hydroxylase inhibitor | 0.318 0.004 DBMET03698 0.607 0.002 DBMET03699 | DBMET03699 | |
| 0.438 | 0.096 | 0.438 | Apoptosis agonist | 0.404 0.112 DBMET03698 | ||
| 0.401 | 0.063 | 0.401 | Transcription factor NF kappa B inhibitor | 0.359 0.074 DBMET03698 0.312 0.088 DBMET03699 | ||
| 0.373 | 0.051 | 0.478 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 DBMET03698 0.478 0.031 DBMET03699 | DBMET03699 | |
| 0.329 | 0.032 | 0.481 | Peroxidase inhibitor | 0.228 0.052 DBMET03698 0.481 0.011 DBMET03699 | DBMET03699 | |
| 0.294 | 0.007 | 0.373 | Histidine decarboxylase inhibitor | 0.159 0.018 DBMET03698 0.373 0.004 DBMET03699 | DBMET03699 | |
| 0.35 | 0.064 | 0.574 | Cholesterol antagonist | 0.38 0.054 DBMET03698 0.574 0.022 DBMET03699 | DBMET03699 | |
| 0.321 | 0.044 | 0.491 | Superoxide dismutase inhibitor | 0.263 0.067 DBMET03698 0.491 0.014 DBMET03699 | DBMET03699 | |
| 0.292 | 0.015 | 0.292 | Neurotensin receptor agonist | 0.238 0.023 DBMET03698 0.274 0.018 DBMET03699 | ||
| 0.277 | 0.004 | 0.289 | Aminopeptidase I inhibitor | 0.287 0.003 DBMET03698 0.289 0.003 DBMET03699 | DBMET03699 | |
| 0.368 | 0.1 | 0.496 | 5 Hydroxytryptamine release inhibitor | 0.324 0.139 DBMET03698 0.496 0.034 DBMET03699 | DBMET03699 | |
| 0.272 | 0.011 | 0.31 | GABA C receptor agonist | 0.139 0.039 DBMET03698 0.31 0.009 DBMET03699 | DBMET03699 | |
| 0.311 | 0.052 | 0.351 | Insulysin inhibitor | 0.234 0.112 DBMET03698 0.351 0.034 DBMET03699 | DBMET03699 | |
| 0.267 | 0.013 | 0.267 | Cystathionine beta-synthase inhibitor | 0.184 0.028 DBMET03698 0.161 0.036 DBMET03699 | ||
| 0.287 | 0.046 | 0.512 | Psychostimulant | 0.247 0.06 DBMET03698 0.512 0.01 DBMET03699 | DBMET03699 | |
| 0.245 | 0.004 | 0.245 | Prolactin inhibitor | 0.187 0.011 DBMET03698 0.168 0.016 DBMET03699 | ||
| 0.272 | 0.038 | 0.34 | Growth hormone agonist | 0.237 0.047 DBMET03698 0.34 0.025 DBMET03699 | DBMET03699 | |
| 0.227 | 0.006 | 0.227 | Carbamoyl phosphate synthetase inhibitor | 0.216 0.007 DBMET03698 0.199 0.007 DBMET03699 | ||
| 0.228 | 0.008 | 0.229 | Antimetabolite | 0.229 0.008 DBMET03698 0.173 0.011 DBMET03699 | DBMET03698 | |
| 0.223 | 0.004 | 0.223 | GABA aminotransferase inhibitor | 0.145 0.009 DBMET03698 0.141 0.01 DBMET03699 | ||
| 0.273 | 0.055 | 0.33 | Gastrin inhibitor | 0.22 0.119 DBMET03698 0.33 0.017 DBMET03699 | DBMET03699 | |
| 0.234 | 0.017 | 0.3 | Cell adhesion inhibitor | 0.173 0.034 DBMET03698 0.3 0.01 DBMET03699 | DBMET03699 | |
| 0.242 | 0.025 | 0.242 | Succinate dehydrogenase inhibitor | 0.232 0.029 DBMET03698 0.221 0.035 DBMET03699 | ||
| 0.231 | 0.016 | 0.231 | Cathepsin H inhibitor | 0.179 0.03 DBMET03698 0.173 0.032 DBMET03699 | ||
| 0.296 | 0.091 | 0.483 | Antithrombotic | 0.359 0.061 DBMET03698 0.483 0.031 DBMET03699 | DBMET03699 | |
| 0.204 | 0.005 | 0.214 | Glutathione S-transferase inhibitor | 0.214 0.005 DBMET03698 0.151 0.012 DBMET03699 | DBMET03698 | |
| 0.196 | 0.007 | 0.196 | Ribonucleoside-diphosphate reductase inhibitor | 0.164 0.009 DBMET03698 0.13 0.014 DBMET03699 | ||
| 0.193 | 0.008 | 0.229 | DOPA decarboxylase inhibitor | 0.158 0.017 DBMET03698 0.229 0.004 DBMET03699 | DBMET03699 | |
| 0.191 | 0.008 | 0.191 | Ribonucleotide reductase inhibitor | 0.16 0.011 DBMET03698 0.126 0.016 DBMET03699 | ||
| 0.251 | 0.078 | 0.353 | Interleukin agonist | 0.2 0.12 DBMET03698 0.353 0.028 DBMET03699 | DBMET03699 | |
| 0.189 | 0.017 | 0.298 | Catalase inhibitor | 0.177 0.02 DBMET03698 0.298 0.006 DBMET03699 | DBMET03699 | |
| 0.277 | 0.108 | 0.382 | Vasodilator, coronary | 0.335 0.063 DBMET03698 0.382 0.041 DBMET03699 | DBMET03699 | |
| 0.176 | 0.009 | 0.219 | Argininosuccinate synthase inhibitor | 0.096 0.02 DBMET03698 0.219 0.007 DBMET03699 | DBMET03699 | |
| 0.237 | 0.071 | 0.302 | Cyclic AMP phosphodiesterase inhibitor | 0.302 0.041 DBMET03698 0.258 0.06 DBMET03699 | DBMET03698 | |
| 0.167 | 0.01 | 0.252 | Glutamate decarboxylase inhibitor | 0.13 0.018 DBMET03698 0.252 0.004 DBMET03699 | DBMET03699 | |
| 0.169 | 0.015 | 0.169 | Triose-phosphate isomerase inhibitor | 0.163 0.017 DBMET03698 0.15 0.02 DBMET03699 | ||
| 0.172 | 0.021 | 0.226 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.043 DBMET03698 0.226 0.012 DBMET03699 | DBMET03699 | |
| 0.223 | 0.073 | 0.283 | Peptidyltransferase inhibitor | 0.24 0.058 DBMET03698 0.283 0.032 DBMET03699 | DBMET03699 | |
| 0.198 | 0.053 | 0.241 | Thrombolytic | 0.174 0.065 DBMET03698 0.241 0.036 DBMET03699 | DBMET03699 | |
| 0.173 | 0.029 | 0.183 | Ferrochelatase inhibitor | 0.183 0.027 DBMET03699 | DBMET03699 | |
| 0.157 | 0.014 | 0.187 | Cell adhesion molecule inhibitor | 0.106 0.031 DBMET03698 0.187 0.01 DBMET03699 | DBMET03699 | |
| 0.255 | 0.111 | 0.363 | Immunomodulator | 0.292 0.087 DBMET03698 0.363 0.056 DBMET03699 | DBMET03699 | |
| 0.226 | 0.083 | 0.322 | Antiamyloidogenic | 0.187 0.109 DBMET03698 0.322 0.045 DBMET03699 | DBMET03699 | |
| 0.172 | 0.03 | 0.184 | Chelator | 0.14 0.039 DBMET03698 0.184 0.027 DBMET03699 | DBMET03699 | |
| 0.227 | 0.087 | 0.229 | Calpain inhibitor | 0.175 0.141 DBMET03698 0.229 0.085 DBMET03699 | DBMET03699 | |
| 0.144 | 0.009 | 0.227 | NMDA receptor agonist | 0.117 0.014 DBMET03698 0.227 0.004 DBMET03699 | DBMET03699 | |
| 0.173 | 0.043 | 0.34 | Alpha-N-acetylglucosaminidase inhibitor | 0.161 0.049 DBMET03698 0.34 0.013 DBMET03699 | DBMET03699 | |
| 0.148 | 0.019 | 0.188 | Aminoacyl-tRNA synthetase inhibitor | 0.14 0.022 DBMET03698 0.188 0.012 DBMET03699 | DBMET03699 | |
| 0.147 | 0.018 | 0.147 | Thioredoxin inhibitor | 0.119 0.032 DBMET03698 | ||
| 0.155 | 0.027 | 0.155 | DNA repair enzyme inhibitor | 0.134 0.049 DBMET03698 | ||
| 0.13 | 0.005 | 0.149 | AMPA 2 receptor antagonist | 0.074 0.008 DBMET03698 0.149 0.004 DBMET03699 | DBMET03699 | |
| 0.149 | 0.025 | 0.183 | NMDA receptor antagonist | 0.093 0.052 DBMET03698 0.183 0.017 DBMET03699 | DBMET03699 | |
| 0.133 | 0.008 | 0.17 | NMDA 2A receptor antagonist | 0.059 0.03 DBMET03698 0.17 0.005 DBMET03699 | DBMET03699 | |
| 0.129 | 0.005 | 0.145 | Kainate receptor antagonist | 0.063 0.015 DBMET03698 0.145 0.005 DBMET03699 | DBMET03699 | |
| 0.146 | 0.024 | 0.17 | Folate antagonist | 0.124 0.036 DBMET03698 0.17 0.016 DBMET03699 | DBMET03699 | |
| 0.181 | 0.06 | 0.294 | Phospholipase C inhibitor | 0.165 0.079 DBMET03698 0.294 0.019 DBMET03699 | DBMET03699 | |
| 0.195 | 0.078 | 0.353 | Insulin sensitizer | 0.227 0.049 DBMET03698 0.353 0.009 DBMET03699 | DBMET03699 | |
| 0.207 | 0.091 | 0.303 | Angiogenesis stimulant | 0.208 0.091 DBMET03698 0.303 0.048 DBMET03699 | DBMET03699 | |
| 0.131 | 0.019 | 0.14 | Ornithine decarboxylase inhibitor | 0.113 0.031 DBMET03698 0.14 0.014 DBMET03699 | DBMET03699 | |
| 0.141 | 0.03 | 0.201 | Adenylate kinase inhibitor | 0.109 0.054 DBMET03698 0.201 0.015 DBMET03699 | DBMET03699 | |
| 0.158 | 0.053 | 0.165 | Bone formation stimulant | 0.152 0.058 DBMET03698 0.165 0.049 DBMET03699 | DBMET03699 | |
| 0.118 | 0.013 | 0.231 | Ornithine carbamoyltransferase inhibitor | 0.107 0.015 DBMET03698 0.231 0.006 DBMET03699 | DBMET03699 | |
| 0.105 | 0.003 | 0.114 | Kainate receptor agonist | 0.067 0.005 DBMET03698 0.114 0.002 DBMET03699 | DBMET03699 | |
| 0.105 | 0.005 | 0.151 | Glutamate (mGluR4) antagonist | 0.063 0.013 DBMET03698 0.151 0.004 DBMET03699 | DBMET03699 | |
| 0.132 | 0.033 | 0.182 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.07 DBMET03698 0.182 0.016 DBMET03699 | DBMET03699 | |
| 0.126 | 0.031 | 0.126 | Alcohol dehydrogenase inhibitor | 0.1 0.052 DBMET03698 0.102 0.051 DBMET03699 | ||
| 0.122 | 0.027 | 0.122 | Cathepsin G inhibitor | 0.069 0.055 DBMET03698 0.071 0.052 DBMET03699 | ||
| 0.104 | 0.009 | 0.127 | Glutamate (mGluR6) antagonist | 0.086 0.019 DBMET03698 0.127 0.005 DBMET03699 | DBMET03699 | |
| 0.092 | 0.002 | 0.105 | Tryptophan hydroxylase 1 inhibitor | 0.058 0.002 DBMET03698 0.105 0.002 DBMET03699 | DBMET03699 | |
| 0.105 | 0.016 | 0.157 | Integrin antagonist | 0.048 0.028 DBMET03698 0.157 0.01 DBMET03699 | DBMET03699 | |
| 0.092 | 0.007 | 0.122 | Integrin alpha4 antagonist | 0.04 0.013 DBMET03698 0.122 0.005 DBMET03699 | DBMET03699 | |
| 0.158 | 0.074 | 0.229 | Anticoagulant | 0.137 0.092 DBMET03698 0.229 0.044 DBMET03699 | DBMET03699 | |
| 0.089 | 0.006 | 0.138 | Glutamate (mGluR group III) antagonist | 0.052 0.018 DBMET03698 0.138 0.004 DBMET03699 | DBMET03699 | |
| 0.096 | 0.013 | 0.104 | Glutamate (mGluR7) antagonist | 0.104 0.009 DBMET03699 | DBMET03699 | |
| 0.133 | 0.05 | 0.133 | DNA intercalator | 0.126 0.054 DBMET03698 | ||
| 0.088 | 0.005 | 0.11 | Kainate receptor 2 antagonist | 0.043 0.02 DBMET03698 0.11 0.004 DBMET03699 | DBMET03699 | |
| 0.133 | 0.052 | 0.133 | Sphingosine 1-phosphate receptor 4 antagonist | 0.113 0.087 DBMET03698 0.116 0.08 DBMET03699 | ||
| 0.119 | 0.038 | 0.218 | Nitric-oxide synthase inhibitor | 0.104 0.054 DBMET03698 0.218 0.007 DBMET03699 | DBMET03699 | |
| 0.083 | 0.003 | 0.094 | Tryptophan 5 hydroxylase inhibitor | 0.056 0.004 DBMET03698 0.094 0.002 DBMET03699 | DBMET03699 | |
| 0.086 | 0.007 | 0.103 | VLA-4 antagonist | 0.05 0.013 DBMET03698 0.103 0.005 DBMET03699 | DBMET03699 | |
| 0.097 | 0.019 | 0.117 | Carbonic anhydrase stimulant | 0.055 0.046 DBMET03698 0.117 0.015 DBMET03699 | DBMET03699 | |
| 0.108 | 0.031 | 0.165 | Inducible nitric-oxide synthase inhibitor | 0.165 0.013 DBMET03699 | DBMET03699 | |
| 0.199 | 0.122 | 0.242 | Neuropeptide Y2 antagonist | 0.242 0.064 DBMET03699 | DBMET03699 | |
| 0.137 | 0.06 | 0.184 | Glutamate receptor antagonist | 0.184 0.031 DBMET03699 | DBMET03699 | |
| 0.147 | 0.071 | 0.18 | Thiol protease inhibitor | 0.136 0.086 DBMET03698 0.18 0.048 DBMET03699 | DBMET03699 | |
| 0.082 | 0.006 | 0.105 | AMPA 4 receptor antagonist | 0.04 0.026 DBMET03698 0.105 0.005 DBMET03699 | DBMET03699 | |
| 0.156 | 0.081 | 0.156 | Arachidonic acid antagonist | 0.149 0.09 DBMET03698 0.14 0.1 DBMET03699 | ||
| 0.125 | 0.051 | 0.189 | Photosensitizer | 0.104 0.081 DBMET03698 0.189 0.015 DBMET03699 | DBMET03699 | |
| 0.08 | 0.007 | 0.082 | Thymidylate synthase inhibitor | 0.078 0.008 DBMET03698 0.082 0.007 DBMET03699 | DBMET03699 | |
| 0.144 | 0.072 | 0.188 | Sphingosine 1-phosphate receptor 5 antagonist | 0.124 0.115 DBMET03698 0.188 0.018 DBMET03699 | DBMET03699 | |
| 0.075 | 0.004 | 0.088 | AMPA receptor agonist | 0.066 0.005 DBMET03698 0.088 0.004 DBMET03699 | DBMET03699 | |
| 0.072 | 0.005 | 0.083 | Glutamate (mGluR8) agonist | 0.049 0.012 DBMET03698 0.083 0.004 DBMET03699 | DBMET03699 | |
| 0.079 | 0.012 | 0.112 | NMDA receptor subunit 3A antagonist | 0.112 0.007 DBMET03699 | DBMET03699 | |
| 0.095 | 0.029 | 0.104 | T cell inhibitor | 0.104 0.021 DBMET03698 0.093 0.032 DBMET03699 | DBMET03698 | |
| 0.072 | 0.006 | 0.114 | Glutamate (mGluR3) antagonist | 0.044 0.017 DBMET03698 0.114 0.004 DBMET03699 | DBMET03699 | |
| 0.116 | 0.051 | 0.129 | Protease inhibitor | 0.11 0.057 DBMET03698 0.129 0.041 DBMET03699 | DBMET03699 | |
| 0.158 | 0.094 | 0.197 | Lipocortins synthesis antagonist | 0.141 0.119 DBMET03698 0.197 0.058 DBMET03699 | DBMET03699 | |
| 0.097 | 0.032 | 0.097 | Thioredoxin reductase inhibitor | 0.087 0.046 DBMET03698 | ||
| 0.099 | 0.037 | 0.099 | Chymotrypsin inhibitor | 0.086 0.047 DBMET03698 0.075 0.062 DBMET03699 | ||
| 0.066 | 0.004 | 0.068 | Glutamate (mGluR8) antagonist | 0.055 0.006 DBMET03698 0.068 0.004 DBMET03699 | DBMET03699 | |
| 0.14 | 0.08 | 0.19 | Adenylate cyclase stimulant | 0.137 0.086 DBMET03698 0.19 0.018 DBMET03699 | DBMET03699 | |
| 0.093 | 0.035 | 0.177 | Phosphofructokinase-1 inhibitor | 0.086 0.038 DBMET03698 0.177 0.014 DBMET03699 | DBMET03699 | |
| 0.12 | 0.065 | 0.12 | Proteasome inhibitor | 0.105 0.081 DBMET03698 0.115 0.069 DBMET03699 | ||
| 0.182 | 0.132 | 0.34 | Hypoglycemic | 0.236 0.086 DBMET03698 0.34 0.04 DBMET03699 | DBMET03699 | |
| 0.107 | 0.059 | 0.107 | Toll-Like receptor 4 antagonist | 0.097 0.074 DBMET03698 0.093 0.082 DBMET03699 | ||
| 0.051 | 0.005 | 0.069 | Integrin alpha4beta7 antagonist | 0.032 0.008 DBMET03698 0.069 0.004 DBMET03699 | DBMET03699 | |
| 0.11 | 0.064 | 0.176 | Mucolytic | 0.093 0.089 DBMET03698 0.176 0.02 DBMET03699 | DBMET03699 | |
| 0.057 | 0.011 | 0.09 | Arginase inhibitor | 0.051 0.014 DBMET03698 0.09 0.004 DBMET03699 | DBMET03699 | |
| 0.105 | 0.059 | 0.111 | Factor V inhibitor | 0.095 0.081 DBMET03698 0.111 0.049 DBMET03699 | DBMET03699 | |
| 0.053 | 0.008 | 0.056 | VCAM-1 antagonist | 0.049 0.01 DBMET03698 0.056 0.006 DBMET03699 | DBMET03699 | |
| 0.053 | 0.008 | 0.055 | VCAM antagonist | 0.048 0.01 DBMET03698 0.055 0.006 DBMET03699 | DBMET03699 | |
| 0.051 | 0.007 | 0.094 | Lysine carboxypeptidase inhibitor | 0.04 0.01 DBMET03698 0.094 0.004 DBMET03699 | DBMET03699 | |
| 0.134 | 0.091 | 0.183 | Insulin secretagoues | 0.118 0.115 DBMET03698 0.183 0.046 DBMET03699 | DBMET03699 | |
| 0.061 | 0.019 | 0.089 | NMDA receptor subunit 3B antagonist | 0.089 0.012 DBMET03699 | DBMET03699 | |
| 0.081 | 0.039 | 0.103 | GABA B receptor agonist | 0.103 0.014 DBMET03699 | DBMET03699 | |
| 0.077 | 0.037 | 0.098 | Glucagon-like peptide 1 agonist | 0.084 0.032 DBMET03698 0.098 0.023 DBMET03699 | DBMET03699 | |
| 0.119 | 0.078 | 0.171 | Cyclooxygenase 3 inhibitor | 0.171 0.033 DBMET03699 | DBMET03699 | |
| 0.215 | 0.175 | 0.23 | Calpain 2 inhibitor | 0.23 0.164 DBMET03699 | DBMET03699 | |
| 0.053 | 0.014 | 0.053 | Membrane dipeptidase inhibitor | 0.045 0.021 DBMET03698 0.052 0.014 DBMET03699 | ||
| 0.052 | 0.013 | 0.06 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET03698 0.06 0.01 DBMET03699 | DBMET03699 | |
| 0.061 | 0.021 | 0.07 | Complement C3a chemotactic receptor antagonist | 0.046 0.029 DBMET03698 0.07 0.018 DBMET03699 | DBMET03699 | |
| 0.053 | 0.015 | 0.059 | Carbonic anhydrase I stimulant | 0.036 0.027 DBMET03698 0.059 0.012 DBMET03699 | DBMET03699 | |
| 0.099 | 0.062 | 0.12 | Glutamate (mGluR7) agonist | 0.12 0.03 DBMET03699 | DBMET03699 | |
| 0.165 | 0.13 | 0.352 | Platelet antagonist | 0.178 0.119 DBMET03698 0.352 0.038 DBMET03699 | DBMET03699 | |
| 0.04 | 0.005 | 0.069 | Glutamate (mGluR1) agonist | 0.026 0.015 DBMET03698 0.069 0.004 DBMET03699 | DBMET03699 | |
| 0.045 | 0.011 | 0.055 | AMPA 3 receptor antagonist | 0.055 0.007 DBMET03699 | DBMET03699 | |
| 0.068 | 0.035 | 0.134 | NMDA 2C receptor antagonist | 0.057 0.049 DBMET03698 0.134 0.008 DBMET03699 | DBMET03699 | |
| 0.04 | 0.007 | 0.051 | Kainate receptor 1 antagonist | 0.051 0.005 DBMET03699 | DBMET03699 | |
| 0.085 | 0.052 | 0.114 | Estrogen-related receptor beta agonist | 0.083 0.058 DBMET03698 0.114 0.013 DBMET03699 | DBMET03699 | |
| 0.086 | 0.055 | 0.086 | Factor XII inhibitor | 0.082 0.062 DBMET03699 | ||
| 0.051 | 0.021 | 0.164 | Erythropoietin receptor agonist | 0.073 0.014 DBMET03698 0.164 0.007 DBMET03699 | DBMET03699 | |
| 0.102 | 0.073 | 0.117 | Nav1.4 sodium channel blocker | 0.117 0.055 DBMET03699 | DBMET03699 | |
| 0.036 | 0.008 | 0.05 | Thyroid hormone agonist | 0.025 0.02 DBMET03698 0.05 0.004 DBMET03699 | DBMET03699 | |
| 0.051 | 0.024 | 0.098 | Mannosidase inhibitor | 0.049 0.026 DBMET03698 0.098 0.006 DBMET03699 | DBMET03699 | |
| 0.038 | 0.012 | 0.051 | Glutamate (mGluR3) agonist | 0.033 0.021 DBMET03698 0.051 0.005 DBMET03699 | DBMET03699 | |
| 0.037 | 0.01 | 0.042 | Kainate receptor 4 antagonist | 0.022 0.02 DBMET03698 0.042 0.009 DBMET03699 | DBMET03699 | |
| 0.074 | 0.047 | 0.112 | Glycine receptor agonist | 0.112 0.015 DBMET03699 | DBMET03699 | |
| 0.121 | 0.095 | 0.168 | Sphingosine 1-phosphate receptor 2 antagonist | 0.168 0.022 DBMET03699 | DBMET03699 | |
| 0.087 | 0.062 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.029 DBMET03699 | DBMET03699 | |
| 0.049 | 0.024 | 0.071 | Glutamate (mGluR group III) agonist | 0.071 0.015 DBMET03699 | DBMET03699 | |
| 0.048 | 0.024 | 0.055 | AICAR transformylase inhibitor | 0.055 0.018 DBMET03699 | DBMET03699 | |
| 0.033 | 0.009 | 0.037 | Kainate receptor 5 antagonist | 0.018 0.017 DBMET03698 0.037 0.007 DBMET03699 | DBMET03699 | |
| 0.062 | 0.039 | 0.062 | Androgen agonist | 0.057 0.045 DBMET03698 | ||
| 0.172 | 0.148 | 0.196 | Nitric-oxide synthase stimulant | 0.196 0.095 DBMET03699 | DBMET03699 | |
| 0.032 | 0.009 | 0.05 | Integrin beta7 antagonist | 0.019 0.014 DBMET03698 0.05 0.006 DBMET03699 | DBMET03699 | |
| 0.061 | 0.039 | 0.091 | Biliverdin reductase inhibitor | 0.091 0.021 DBMET03699 | DBMET03699 | |
| 0.074 | 0.052 | 0.104 | Porphobilinogen synthase inhibitor | 0.104 0.034 DBMET03699 | DBMET03699 | |
| 0.044 | 0.023 | 0.064 | Leukotriene A4 hydrolase inhibitor | 0.032 0.031 DBMET03698 0.064 0.014 DBMET03699 | DBMET03699 | |
| 0.116 | 0.096 | 0.169 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 DBMET03699 | DBMET03699 | |
| 0.056 | 0.036 | 0.064 | Angiotensin-converting enzyme inhibitor | 0.064 0.025 DBMET03699 | DBMET03699 | |
| 0.054 | 0.035 | 0.089 | Alpha-mannosidase inhibitor | 0.053 0.038 DBMET03698 0.089 0.008 DBMET03699 | DBMET03699 | |
| 0.035 | 0.017 | 0.065 | AMPA 1 receptor antagonist | 0.065 0.009 DBMET03699 | DBMET03699 | |
| 0.082 | 0.065 | 0.11 | Histamine N-methyltransferase inhibitor | 0.11 0.037 DBMET03699 | DBMET03699 | |
| 0.075 | 0.058 | 0.085 | Somatostatin 1 agonist | 0.085 0.046 DBMET03699 | DBMET03699 | |
| 0.142 | 0.125 | 0.176 | Catenin beta inhibitor | 0.176 0.057 DBMET03699 | DBMET03699 | |
| 0.039 | 0.023 | 0.039 | Integrin alpha1beta1 antagonist | 0.039 0.023 DBMET03699 | ||
| 0.023 | 0.007 | 0.027 | Kainate receptor 3 antagonist | 0.016 0.013 DBMET03698 0.027 0.006 DBMET03699 | DBMET03699 | |
| 0.09 | 0.074 | 0.09 | UDP-glucose 4-epimerase inhibitor | 0.085 0.081 DBMET03699 | ||
| 0.038 | 0.023 | 0.045 | Integrin alpha2 antagonist | 0.045 0.015 DBMET03699 | DBMET03699 | |
| 0.089 | 0.076 | 0.108 | Bile acid receptor antagonist | 0.108 0.034 DBMET03699 | DBMET03699 | |
| 0.035 | 0.021 | 0.056 | Prostacyclin antagonist | 0.056 0.01 DBMET03699 | DBMET03699 | |
| 0.047 | 0.033 | 0.058 | Adenosine deaminase inhibitor | 0.046 0.034 DBMET03698 0.058 0.023 DBMET03699 | DBMET03699 | |
| 0.054 | 0.042 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | 0.059 0.031 DBMET03698 0.061 0.027 DBMET03699 | DBMET03699 | |
| 0.028 | 0.015 | 0.033 | Integrin alpha2beta1 antagonist | 0.033 0.01 DBMET03699 | DBMET03699 | |
| 0.02 | 0.007 | 0.021 | Thyroid hormone alpha agonist | 0.016 0.011 DBMET03698 0.021 0.006 DBMET03699 | DBMET03699 | |
| 0.123 | 0.112 | 0.223 | Phospholipase A2 inhibitor | 0.223 0.032 DBMET03699 | DBMET03699 | |
| 0.09 | 0.079 | 0.09 | Anabolic | |||
| 0.016 | 0.005 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 DBMET03699 | DBMET03699 | |
| 0.031 | 0.021 | 0.064 | Endothelial nitric-oxide synthase inhibitor | 0.064 0.006 DBMET03699 | DBMET03699 | |
| 0.045 | 0.036 | 0.061 | GP IIb/IIIa receptor antagonist | 0.061 0.027 DBMET03699 | DBMET03699 | |
| 0.105 | 0.096 | 0.183 | Toll-Like receptor 2 antagonist | 0.183 0.032 DBMET03699 | DBMET03699 | |
| 0.043 | 0.034 | 0.054 | Neurotensin receptor antagonist | 0.054 0.026 DBMET03699 | DBMET03699 | |
| 0.032 | 0.024 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.017 DBMET03699 | DBMET03699 | |
| 0.118 | 0.11 | 0.151 | Farnesoid X receptor antagonist | 0.151 0.051 DBMET03699 | DBMET03699 | |
| 0.057 | 0.049 | 0.102 | NMDA receptor glycine site agonist | 0.102 0.015 DBMET03699 | DBMET03699 | |
| 0.052 | 0.045 | 0.067 | Aminopeptidase microsomal inhibitor | 0.067 0.033 DBMET03699 | DBMET03699 | |
| 0.198 | 0.191 | 0.354 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 DBMET03698 0.354 0.037 DBMET03699 | DBMET03699 | |
| 0.136 | 0.129 | 0.136 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.188 | 0.183 | 0.193 | Thioredoxin glutathione reductase inhibitor | 0.193 0.179 DBMET03698 | DBMET03698 | |
| 0.055 | 0.05 | 0.056 | Lipocortins synthesis agonist | 0.056 0.046 DBMET03698 | DBMET03698 | |
| 0.038 | 0.033 | 0.044 | Integrin alpha5beta1 antagonist | 0.044 0.024 DBMET03699 | DBMET03699 | |
| 0.021 | 0.017 | 0.025 | Glutamate (mGluR1a) agonist | 0.025 0.012 DBMET03699 | DBMET03699 | |
| 0.059 | 0.055 | 0.163 | Sphingosine 1-phosphate receptor 4 agonist | 0.079 0.037 DBMET03698 0.163 0.007 DBMET03699 | DBMET03699 | |
| 0.1 | 0.096 | 0.121 | Amylase inhibitor | 0.121 0.08 DBMET03699 | DBMET03699 | |
| 0.028 | 0.025 | 0.028 | Caspase 2 inhibitor | |||
| 0.017 | 0.013 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.012 DBMET03699 | DBMET03699 | |
| 0.059 | 0.057 | 0.064 | Prolactin release inhibitor | 0.064 0.038 DBMET03699 | DBMET03699 | |
| 0.033 | 0.03 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.03 DBMET03699 | ||
| 0.084 | 0.082 | 0.122 | Interleukin 1 beta converting enzyme inhibitor | 0.122 0.033 DBMET03699 | DBMET03699 | |
| 0.047 | 0.045 | 0.06 | Aconitate hydratase inhibitor | 0.06 0.025 DBMET03699 | DBMET03699 | |
| 0.014 | 0.013 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.011 DBMET03699 | DBMET03699 | |
| 0.024 | 0.024 | 0.029 | NMDA 2D receptor antagonist | 0.029 0.017 DBMET03699 | DBMET03699 | |
| 0.044 | 0.044 | 0.067 | Bombesin 2 receptor antagonist | 0.067 0.021 DBMET03699 | DBMET03699 | |
| 0.078 | 0.079 | 0.109 | Hematopoietic | 0.081 0.07 DBMET03698 0.109 0.028 DBMET03699 | DBMET03699 | |
| 0.031 | 0.031 | 0.034 | Glutamate (mGluR4) agonist | 0.034 0.023 DBMET03699 | DBMET03699 | |
| 0.02 | 0.021 | 0.021 | Aminopeptidase P inhibitor | 0.021 0.019 DBMET03699 | DBMET03699 | |
| 0.041 | 0.043 | 0.053 | AMPA receptor antagonist | 0.053 0.029 DBMET03699 | DBMET03699 | |
| 0.012 | 0.014 | 0.026 | Integrin alpha4beta1 antagonist | 0.026 0.008 DBMET03699 | DBMET03699 | |
| 0.051 | 0.053 | 0.085 | Opioid delta receptor antagonist | 0.085 0.035 DBMET03699 | DBMET03699 | |
| 0.027 | 0.03 | 0.049 | Calcitonin receptor agonist | 0.049 0.017 DBMET03699 | DBMET03699 | |
| 0.033 | 0.037 | 0.112 | Toll-Like receptor 2 agonist | 0.039 0.03 DBMET03698 0.112 0.014 DBMET03699 | DBMET03699 | |
| 0.032 | 0.036 | 0.037 | Cholecystokinin B agonist | 0.037 0.027 DBMET03699 | DBMET03699 | |
| 0.046 | 0.05 | 0.05 | Carbonic anhydrase II stimulant | 0.05 0.04 DBMET03699 | DBMET03699 | |
| 0.016 | 0.021 | 0.019 | Integrin alphaVbeta1 antagonist | 0.019 0.014 DBMET03699 | DBMET03699 | |
| 0.093 | 0.098 | 0.119 | Histone deacetylase class III inhibitor | 0.119 0.071 DBMET03699 | DBMET03699 | |
| 0.058 | 0.065 | 0.143 | NMDA 2 receptor antagonist | 0.143 0.018 DBMET03699 | DBMET03699 | |
| 0.006 | 0.013 | 0.009 | Thyroid hormone beta agonist | 0.009 0.006 DBMET03699 | DBMET03699 | |
| 0.037 | 0.044 | 0.048 | Aminopeptidase N inhibitor | 0.048 0.033 DBMET03699 | DBMET03699 | |
| 0.022 | 0.031 | 0.029 | Bradykinin B2 receptor agonist | 0.029 0.019 DBMET03699 | DBMET03699 | |
| 0.044 | 0.053 | 0.191 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET03698 0.191 0.007 DBMET03699 | DBMET03699 | |
| 0.056 | 0.066 | 0.073 | Sirtuin 1 inhibitor | 0.073 0.041 DBMET03699 | DBMET03699 | |
| 0.111 | 0.122 | 0.163 | Acetylcholine M1 receptor antagonist | 0.163 0.064 DBMET03699 | DBMET03699 | |
| 0.059 | 0.071 | 0.071 | Thrombin inhibitor | 0.071 0.054 DBMET03699 | DBMET03699 | |
| 0.055 | 0.067 | 0.062 | Trypsin inhibitor | 0.062 0.043 DBMET03699 | DBMET03699 | |
| 0.071 | 0.083 | 0.1 | Opioid antagonist | 0.1 0.048 DBMET03699 | DBMET03699 | |
| 0.033 | 0.045 | 0.042 | Endothelin-converting enzyme inhibitor | 0.042 0.037 DBMET03699 | DBMET03699 | |
| 0.033 | 0.046 | 0.039 | Neurokinin 2 agonist | 0.039 0.031 DBMET03699 | DBMET03699 | |
| 0.022 | 0.037 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.022 DBMET03699 | DBMET03699 | |
| 0.049 | 0.066 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 DBMET03699 | DBMET03699 | |
| 0.047 | 0.065 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.038 DBMET03699 | DBMET03699 | |
| 0.079 | 0.098 | 0.146 | Expectorant | 0.146 0.037 DBMET03699 | DBMET03699 | |
| 0.039 | 0.058 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.024 DBMET03699 | DBMET03699 | |
| 0.106 | 0.127 | 0.156 | Vanilloid 1 agonist | 0.156 0.033 DBMET03699 | DBMET03699 | |
| 0.085 | 0.106 | 0.104 | GABA C receptor antagonist | 0.104 0.073 DBMET03699 | DBMET03699 | |
| 0.031 | 0.052 | 0.065 | Glycine transporter 2 inhibitor | 0.065 0.023 DBMET03699 | DBMET03699 | |
| 0.066 | 0.087 | 0.076 | Sphingosine 1-phosphate receptor antagonist | 0.076 0.054 DBMET03699 | DBMET03699 | |
| 0.075 | 0.097 | 0.154 | Creatine kinase inhibitor | 0.154 0.022 DBMET03699 | DBMET03699 | |
| 0.059 | 0.081 | 0.069 | Analgesic, opioid | 0.069 0.064 DBMET03699 | DBMET03699 | |
| 0.021 | 0.044 | 0.027 | Motilin receptor antagonist | 0.027 0.02 DBMET03699 | DBMET03699 | |
| 0.047 | 0.072 | 0.066 | Opioid mu receptor antagonist | 0.066 0.049 DBMET03699 | DBMET03699 | |
| 0.103 | 0.129 | 0.115 | Neurotrophic factor | 0.115 0.103 DBMET03699 | DBMET03699 | |
| 0.013 | 0.039 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 DBMET03699 | DBMET03699 | |
| 0.037 | 0.065 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.032 DBMET03699 | DBMET03699 | |
| 0.032 | 0.062 | 0.051 | Neuropeptide agonist | 0.051 0.042 DBMET03699 | DBMET03699 | |
| 0.028 | 0.06 | 0.141 | Phosphorylase inhibitor | 0.048 0.032 DBMET03698 0.141 0.008 DBMET03699 | DBMET03699 | |
| 0.058 | 0.092 | 0.089 | Peroxisome proliferator-activated receptor gamma antagonist | 0.089 0.023 DBMET03699 | DBMET03699 | |
| 0.02 | 0.056 | 0.046 | Growth hormone secretagogue receptor antagonist | 0.046 0.019 DBMET03699 | DBMET03699 | |
| 0.074 | 0.114 | 0.093 | GABA C receptor rho-1 antagonist | 0.093 0.073 DBMET03699 | DBMET03699 | |
| 0.025 | 0.066 | 0.058 | GABA uptake inhibitor | 0.058 0.011 DBMET03699 | DBMET03699 | |
| 0.048 | 0.089 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | 0.072 0.035 DBMET03699 | DBMET03699 | |
| 0.016 | 0.06 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 DBMET03699 | DBMET03699 | |
| 0.085 | 0.13 | 0.163 | Aldehyde dehydrogenase inhibitor | 0.163 0.04 DBMET03699 | DBMET03699 | |
| 0.115 | 0.162 | 0.179 | Hepatoprotectant | 0.179 0.08 DBMET03699 | DBMET03699 | |
| 0.039 | 0.086 | 0.069 | Neutrophil collagenase inhibitor | 0.069 0.04 DBMET03699 | DBMET03699 | |
| 0.061 | 0.108 | 0.131 | Monophenol monooxygenase inhibitor | 0.131 0.055 DBMET03699 | DBMET03699 | |
| 0.056 | 0.107 | 0.1 | Keratolytic | 0.1 0.03 DBMET03699 | DBMET03699 | |
| 0.014 | 0.071 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 DBMET03699 | DBMET03699 | |
| 0.121 | 0.185 | 0.14 | Heat shock protein 70 antagonist | 0.14 0.076 DBMET03699 | DBMET03699 | |
| 0.107 | 0.172 | 0.134 | Interferon gamma antagonist | 0.134 0.103 DBMET03699 | DBMET03699 | |
| 0.031 | 0.099 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 DBMET03699 | DBMET03699 | |
| 0.102 | 0.171 | 0.325 | Platelet adhesion inhibitor | 0.21 0.066 DBMET03698 0.325 0.026 DBMET03699 | DBMET03699 | |
| 0.081 | 0.151 | 0.115 | NADPH oxidase inhibitor | 0.115 0.09 DBMET03699 | DBMET03699 | |
| 0.052 | 0.122 | 0.111 | Carbonic anhydrase VI inhibitor | 0.111 0.033 DBMET03699 | DBMET03699 | |
| 0.044 | 0.116 | 0.086 | Interferon inducer | 0.086 0.02 DBMET03699 | DBMET03699 | |
| 0.019 | 0.093 | 0.037 | Factor XIIIa inhibitor | 0.037 0.026 DBMET03699 | DBMET03699 | |
| 0.051 | 0.125 | 0.112 | Interferon agonist | 0.112 0.021 DBMET03699 | DBMET03699 | |
| 0.06 | 0.134 | 0.105 | Protein-tyrosine phosphatase 1B inhibitor | 0.105 0.073 DBMET03699 | DBMET03699 | |
| 0.03 | 0.105 | 0.066 | Selectin antagonist | 0.066 0.045 DBMET03699 | DBMET03699 | |
| 0.119 | 0.194 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.099 DBMET03699 | DBMET03699 | |
| 0.037 | 0.113 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.037 DBMET03699 | DBMET03699 | |
| 0.09 | 0.166 | 0.152 | Protein-tyrosine phosphatase inhibitor | 0.152 0.076 DBMET03699 | DBMET03699 | |
| 0.014 | 0.09 | 0.024 | ICAM 1 antagonist | 0.024 0.014 DBMET03699 | DBMET03699 | |
| 0.046 | 0.127 | 0.073 | Metalloproteinase-2 inhibitor | 0.073 0.06 DBMET03699 | DBMET03699 | |
| 0.13 | 0.212 | 0.199 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.199 0.073 DBMET03699 | DBMET03699 | |
| 0.062 | 0.146 | 0.115 | Carbonic anhydrase III inhibitor | 0.115 0.048 DBMET03699 | DBMET03699 | |
| 0.047 | 0.132 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.036 DBMET03699 | DBMET03699 | |
| 0.063 | 0.15 | 0.205 | Adenylate cyclase inhibitor | 0.205 0.025 DBMET03699 | DBMET03699 | |
| 0.106 | 0.196 | 0.27 | Aldehyde oxidase inhibitor | 0.27 0.075 DBMET03699 | DBMET03699 | |
| 0.194 | 0.284 | 0.288 | Calcium channel L-type activator | 0.288 0.168 DBMET03699 | DBMET03699 | |
| 0.078 | 0.169 | 0.138 | Interleukin 8 antagonist | 0.138 0.042 DBMET03699 | DBMET03699 | |
| 0.016 | 0.109 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.024 DBMET03699 | DBMET03699 | |
| 0.017 | 0.114 | 0.055 | Carbonic anhydrase VB inhibitor | 0.055 0.04 DBMET03699 | DBMET03699 | |
| 0.023 | 0.12 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.038 DBMET03699 | DBMET03699 | |
| 0.028 | 0.136 | 0.085 | Peroxisome proliferator-activated receptor gamma agonist | 0.085 0.037 DBMET03699 | DBMET03699 | |
| 0.03 | 0.139 | 0.062 | Carbonic anhydrase VA inhibitor | 0.062 0.057 DBMET03699 | DBMET03699 | |
| 0.02 | 0.129 | 0.043 | Carbonic anhydrase XIV inhibitor | 0.043 0.041 DBMET03699 | DBMET03699 | |
| 0.021 | 0.132 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.022 DBMET03699 | DBMET03699 | |
| 0.031 | 0.143 | 0.077 | Glutamate receptor agonist | 0.077 0.056 DBMET03699 | DBMET03699 | |
| 0.031 | 0.142 | 0.055 | Epithelial sodium channel blocker | 0.055 0.037 DBMET03699 | DBMET03699 | |
| 0.094 | 0.206 | 0.145 | Melanin inhibitor | 0.145 0.089 DBMET03699 | DBMET03699 | |
| 0.05 | 0.161 | 0.094 | Falcipain 3 inhibitor | 0.094 0.077 DBMET03699 | DBMET03699 | |
| 0.032 | 0.145 | 0.069 | Sphingosine kinase inhibitor | 0.069 0.026 DBMET03699 | DBMET03699 | |
| 0.029 | 0.143 | 0.051 | Sphingosine kinase 2 inhibitor | 0.051 0.045 DBMET03699 | DBMET03699 | |
| 0.007 | 0.124 | 0.032 | Sphingosine 1-phosphate receptor 3 agonist | 0.032 0.026 DBMET03699 | DBMET03699 | |
| 0.029 | 0.151 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.042 DBMET03699 | DBMET03699 | |
| 0.075 | 0.2 | 0.175 | Amyloid beta aggregation inhibitor | 0.175 0.092 DBMET03699 | DBMET03699 | |
| 0.014 | 0.14 | 0.058 | Sphingosine 1-phosphate receptor 1 agonist | 0.058 0.014 DBMET03699 | DBMET03699 | |
| 0.031 | 0.157 | 0.073 | Carbonic anhydrase XIII inhibitor | 0.073 0.055 DBMET03699 | DBMET03699 | |
| 0.089 | 0.222 | 0.214 | DNA methylase inhibitor | 0.214 0.07 DBMET03699 | DBMET03699 | |
| 0.022 | 0.156 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET03699 | DBMET03699 | |
| 0.086 | 0.222 | 0.152 | Hemostatic | 0.152 0.066 DBMET03699 | DBMET03699 | |
| 0.084 | 0.22 | 0.132 | Neuropeptide Y1 antagonist | 0.132 0.095 DBMET03699 | DBMET03699 | |
| 0.105 | 0.242 | 0.187 | Antioxidant | 0.187 0.125 DBMET03699 | DBMET03699 | |
| 0.038 | 0.177 | 0.113 | Myeloperoxidase inhibitor | 0.113 0.024 DBMET03699 | DBMET03699 | |
| 0.051 | 0.196 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.021 DBMET03699 | DBMET03699 | |
| 0.052 | 0.198 | 0.112 | Acetylcholine muscarinic antagonist | 0.112 0.077 DBMET03699 | DBMET03699 | |
| 0.016 | 0.163 | 0.085 | Glutamate (mGluR1) antagonist | 0.085 0.021 DBMET03699 | DBMET03699 | |
| 0.038 | 0.185 | 0.083 | Adrenaline agonist | 0.083 0.053 DBMET03699 | DBMET03699 | |
| 0.03 | 0.182 | 0.066 | Phospholipase D inhibitor | 0.066 0.063 DBMET03699 | DBMET03699 | |
| 0.079 | 0.233 | 0.185 | DNA methyltransferase I inhibitor | 0.185 0.077 DBMET03699 | DBMET03699 | |
| 0.143 | 0.301 | 0.279 | Histamine release inhibitor | 0.279 0.135 DBMET03699 | DBMET03699 | |
| 0.02 | 0.182 | 0.034 | Adenosine uptake inhibitor | 0.034 0.026 DBMET03699 | DBMET03699 | |
| 0.016 | 0.179 | 0.061 | Sphingosine 1-phosphate receptor agonist | 0.061 0.016 DBMET03699 | DBMET03699 | |
| 0.078 | 0.245 | 0.212 | Interleukin antagonist | 0.212 0.078 DBMET03699 | DBMET03699 | |
| 0.049 | 0.22 | 0.1 | DNA polymerase I inhibitor | 0.1 0.086 DBMET03699 | DBMET03699 | |
| 0.088 | 0.272 | 0.224 | Vasodilator | 0.155 0.15 DBMET03698 0.224 0.087 DBMET03699 | DBMET03699 | |
| 0.049 | 0.234 | 0.119 | Lipid peroxidase inhibitor | 0.119 0.094 DBMET03699 | DBMET03699 | |
| 0.065 | 0.257 | 0.152 | Cell wall synthesis inhibitor | 0.152 0.063 DBMET03699 | DBMET03699 | |
| 0.027 | 0.228 | 0.118 | Anesthetic local | 0.118 0.069 DBMET03699 | DBMET03699 | |
| 0.026 | 0.23 | 0.102 | Calcium antagonist | 0.102 0.046 DBMET03699 | DBMET03699 | |
| 0.125 | 0.342 | 0.218 | Apoptosis antagonist | 0.218 0.159 DBMET03699 | DBMET03699 | |
| 0.064 | 0.283 | 0.166 | Anticonvulsant | 0.166 0.111 DBMET03699 | DBMET03699 | |
| 0.091 | 0.314 | 0.205 | Thyroid hormone antagonist | 0.205 0.157 DBMET03699 | DBMET03699 | |
| 0.064 | 0.324 | 0.151 | Interleukin 6 antagonist | 0.151 0.088 DBMET03699 | DBMET03699 | |
| 0.099 | 0.36 | 0.391 | Vasodilator, peripheral | 0.391 0.058 DBMET03699 | DBMET03699 | |
| 0.117 | 0.435 | 0.423 | Cyclophilin D inhibitor | 0.423 0.079 DBMET03699 | DBMET03699 | |
| 0.045 | 0.385 | 0.137 | Amyloid beta precursor protein antagonist | 0.137 0.117 DBMET03699 | DBMET03699 | |
| 0.039 | 0.41 | 0.154 | Hypolipemic | 0.154 0.132 DBMET03699 | DBMET03699 | |
| 0.044 | 0.418 | 0.092 | Interleukin 12 antagonist | 0.092 0.069 DBMET03699 | DBMET03699 | |
| 0.059 | 0.458 | 0.106 | Sphingosine 1-phosphate receptor 2 agonist | 0.106 0.086 DBMET03699 | DBMET03699 | |
| 0.031 | 0.501 | 0.143 | Platelet aggregation inhibitor | 0.143 0.138 DBMET03699 | DBMET03699 | |
| 0.026 | 0.557 | 0.088 | Interleukin 5 antagonist | 0.088 0.057 DBMET03699 | DBMET03699 | |
| 0.024 | 0.645 | 0.205 | Cardiotonic | 0.205 0.114 DBMET03699 | DBMET03699 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |